Envista Holdings Corp

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Envista Holdings Corp posts robust 2022 results amidst market challenges

Envista Holdings Corp reported strong 2022 performance with core sales growth and expanded EBITDA margins. Despite Q4 challenges, the company remains optimistic about long-term growth prospects in the dental market. Envista's strategic focus on innovation, operational efficiency, and disciplined growth strategies underpin its commitment to achieving long-term targets and driving shareholder value.

Envista Holdings Corp reports Q1 challenges but sees growth opportunities

Envista Holdings Corp faces challenges in core sales and EBITDA margins in Q1 2023, with a focus on accelerating organic growth and improving the E&C business. Despite short-term uncertainties in China and Russia, the company sees opportunities in expanding margins and driving growth through strategic shifts.

Envista Holdings Corp reports solid Q2 performance amidst market challenges

Envista Holdings Corp (NVST) delivered a resilient performance in Q2 2023, showcasing strengths in core revenue growth, operational improvements, and cash flow generation. While facing challenges in certain segments and regions, the company remains optimistic about achieving its full-year guidance and capitalizing on growth opportunities through strategic initiatives.

Envista Holdings Corp reports positive Q3 performance amidst challenges

Envista Holdings Corp reported positive core growth and margin performance in Q3 2023.
Challenges in the implant business and distribution channels are being addressed through strategic investments.
The company is committed to balancing growth and margin expansion for long-term success.
Envista reaffirms its dedication to navigating challenges and driving future growth.

Envista Holdings Corp reports mixed 2023 performance, eyes growth opportunities

Envista Holdings Corp's 2023 performance showed mixed results with challenges in the global dental market and specific issues impacting segments like Equipment & Consumables. Despite these challenges, the company is focusing on optimizing operations, accelerating key businesses, and navigating short-term issues to drive long-term growth. Envista remains cautiously optimistic about 2024, expecting low single-digit core sales growth and improved margins.

Envista reports modest Q1 growth, eyes China for expansion

Envista Holdings Corp (NVST) reported modest Q1 growth, with a focus on accelerating orthodontic and implant businesses, driving operational improvements, and addressing market challenges.
The company is optimistic about its growth potential in China, aiming to close the gap in market growth in North America and reinvigorate growth in the region.
Envista's strategic investments, focus on cost optimization, and plans for talent acquisition position the company for long-term value creation and success in the industry.

Envista Holdings Corp reports Q2 challenges but sees growth opportunities

Envista Holdings Corp faced challenges with core sales decline and impairment charges but improved free cash flow significantly.
Despite the setbacks, the company made strategic investments and saw growth in active Spark doctors and international expansion.
Envista's focus on market conditions, new appointments, and expanding Spark presents opportunities for future growth and success.

Envista Holdings Corp reports mixed Q3 results, eyes margin improvement

Envista's Q3 performance reflects a mix of strengths and challenges, with opportunities for margin improvement and market expansion.
Strong free cash flow and growth in specific segments demonstrate operational resilience and strategic focus.
Management's optimism for future performance indicates confidence in the company's ability to navigate current market dynamics.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Envista (NVST) delivered earnings and revenue surprises of 6.12% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Surpasses Q4 Earnings and Revenue Estimates

BREA, Calif. , Feb. 8, 2023 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the fourth quarter 2022 and fiscal year 2022.

Envista Reports Fourth Quarter 2022 Earnings

Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Envista (NVST) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

NVST is focused on high growth segments that have a total TAM of $27 billion. NVST has a comprehensive portfolio and global reach to drive sales.

Envista: Positive Long-Term Outlook

BREA, Calif. , Jan. 30, 2023 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced that the company will be holding an Investor Access Event at its Envista Summit on Friday, February 24 th from 8:00 am – 10:00 am PT.

Envista to Hold an Investor Access Event at Envista Summit

BREA, Calif. , Jan. 12, 2023 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2022 on Wednesday, February 8, 2023.

Envista Schedules Fourth Quarter 2022 Earnings Call

BREA, Calif. , Dec. 22, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 41st Annual J.P.

Envista Announces Participation in 41st Annual J.P. Morgan Healthcare Conference

BREA, Calif. , Nov. 7, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate virtually in the Evercore ISI 5th Annual HEALTHCONx Conference on Wednesday, November 30, 2022, from 11:20 am – 12:05 pm ET.

Envista Announces Participation in Evercore ISI 5th Annual HEALTHCONx Conference

With more than 30 trusted brands, Envista reports that 90% of dentists have some of the company's products in their offices. I expect Envista to grow thanks to the digitization of dental practices globally.

Envista: FCF Model Indicates Undervalued Territory

Envista Holdings Corporation (NYSE:NVST ) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Stephen Keller - VP-IR Amir Aghdaei - President and CEO Howard Yu - CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Michael Cherny - Bank of America Jeff Johnson - Baird Jon Block - Stifel Erin Wright - Morgan Stanley Nathan Rich - Goldman Sachs Operator My name is Britney, and I will be your conference call facilitator this afternoon. At this time, I would like to welcome everyone to the Envista Holdings Corporation's Third Quarter 2022 Earnings Results Conference Call.

Envista Holdings Corporation (NVST) Q3 2022 Earnings Call Transcript

Envista (NVST) delivered earnings and revenue surprises of 0% and 0.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Q3 Earnings Match Estimates

BREA, Calif. , Nov. 3, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2022.

Envista Reports Third Quarter 2022 Earnings

BREA, Calif. , Oct. 27, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2021 Sustainability Report, highlighting the Company's progress and approach to embedding environmental, social, and governance (ESG) principles into its strategy to digitize, personalize, and democratize oral care.

Envista Announces Release of 2021 Sustainability Report

Envista (NVST) Earnings Expected to Grow: Should You Buy?

BREA, Calif. , Oct. 4, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2022 on Thursday, November 3, 2022.

Envista Schedules Third Quarter 2022 Earnings Call

BREA, Calif. , Aug. 11, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Piper Sandler MedTech and Diagnostics California Bus Tour on Wednesday, August 24, 2022, from 10:00 – 10:50 AM PT in Laguna Niguel, California.

Envista Announces Participation in Piper Sandler MedTech and Diagnostics California Bus Tour

Envista Holdings Corporation (NYSE:NVST ) Q2 2022 Earnings Conference Call August 3, 2022 5:00 PM ET Company Participants Stephen Keller – Vice President-Investor Relations Amir Aghdaei – President and Chief Executive Officer Howard Yu – Chief Financial Officer Conference Call Participants Elizabeth Anderson – Evercore ISI Jeff Johnson – Baird Jon Block – Stifel Michael Cherny – Bank of America Nathan Rich – Goldman Sachs Operator My name is Chelsea, and I will be your conference call facilitator this afternoon. At this time, I would like to welcome everyone to Envista Holdings Corporation's Second Quarter 2022 Earnings Results Conference Call.

Envista Holdings Corporation's (NVST) CEO Amir Aghdaei on Q2 2022 Results - Earnings Call Transcript

Envista (NVST) delivered earnings and revenue surprises of 4.35% and 1.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Q2 Earnings Top Estimates

BREA, Calif. , Aug. 3, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the second quarter 2022.

Envista Reports Second Quarter 2022 Earnings

Envista Holdings is performing a bit soft from an operational view if you ask me. The company is active on the buy and sell side of M&A here.

Envista Holdings: Not Sinking My Teeth In Yet

BREA, Calif. , July 13, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2022 on Wednesday, August 3, 2022.

Envista Schedules Second Quarter 2022 Earnings Call

BREA, Calif. , May 19, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Stifel 2022 Jaws & Paws Conference on Wednesday, June 1, 2022, from 9:45 – 10:15 AM EST in New York, New York.

Envista Announces Participation in Stifel 2022 Jaws & Paws Conference

BREA, Calif. , May 17, 2022  /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC and OBI Biologics, Inc (together "Osteogenics").

ENVISTA TO ACQUIRE OSTEOGENICS BIOMEDICAL BUSINESS

BREA, Calif. , May 16, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in William Blair Emerging Technologies in Dental Care Virtual Conference on Tuesday, May 17 th from 7:00 – 7:45 AM PT.

Envista Announces Participation in William Blair Emerging Technologies in Dental Care Virtual Conference

Envista Holdings Corp, Inc. (NYSE:NVST ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Stephen Keller - Vice President, Investor Relations Amir Aghdaei - President, CEO & Director Howard Yu - Senior VP & CFO Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Elizabeth Anderson - Evercore ISI Erin Wright - Morgan Stanley Nathan Rich - Goldman Sachs Group Michael Cherny - Bank of America Merrill Lynch Jason Bednar - Piper Sandler & Co. Jonathan Block - Stifel, Nicolaus & Company Operator My name is Chelsea, and I will be your conference call facilitator this afternoon.

News for Envista Holdings Corp Stock (NVST)